Press Room

12th Global Drug Delivery & Formulation Virtual Summit

Start
Monday, March 15, 2021 - 00:00
End
Wednesday, March 17, 2021 - 00:00
Location: online
Drug Delivery Formulation | Hovione

At Hovione we are constantly innovating to find better and more efficient ways of doing things.

Visit Hovione’s booth at the 12th Global Drug Delivery and Formulation Summit (DDF) and meet our team of experts.



Learn more about ASD-HIPROS – the most advanced and accurate screening platform able to identify the most efficient and stable Amorphous Solid Dispersion formulations by Spray Drying. Requiring as little as 5g of API and in just 6 weeks, this platform maximizes your chances of identifying a successful formulation, accelerating development towards commercial manufacturing and patient availability.

Schedule a meeting button | Hovione





Don’t miss our “Technology & Innovation” Session

Featured Speakers: Mafalda Paiva - Group Leader, R&D Analytical Development and João Henriques - Group Leader, R&D Drug Product Development

Title: Performance Enhancement Strategies for Low Solubility APIs – do more with less

Session Track: Technology & Innovation

Date: Wednesday, March 17, 2021

Time: 09:25AM – 10:00AM GMT

Abstract: The presentation will address the main challenges in the formulation of ASDs, highlighting the importance of integrated development and the synergies between pre-formulation and commercial manufacturing expertise. Mafalda and João will also be presenting ASD HIPROS, our new state-of-the-art, science-based development platform for ASDs.

Conference Website: httpss://www.ddfevent.com/ 

12th Global Drug Delivery & Formulation Virtual Summit | Hovione

 

 

Interested in turning your most difficult challenge into a successful solution?

 

 

Schedule a meeting with our experts

 





 

You might be interested in:









 

Also in the Press Room

See All

In an interview with Executiva, a portuguese media outlet focused on women´s leadership, Diane Villax, co-founder and long-standing leader of Hovione, reflects on her journey and the company’s development over more than six decades. Diane Villax’s career began at a time when few women worked outside the home. At 19, she joined a trading company as a foreign languages correspondent, where she developed essential business skills — including commercial correspondence, banking and export procedures — that later proved instrumental in helping her husband, Ivan Villax, establish Hovione in 1959. From its earliest days operating in the family home in Lisbon, Hovione adopted an international outlook. The company’s first major customers were in Japan, setting demanding quality standards that helped shape its long-term position in global markets. Over the following decades, Hovione expanded its footprint with the construction of its first manufacturing site in Loures (1969), followed by expansion to Macau (1986), the United States (New Jersey, early 2000s) and Ireland (Cork). The company grew into a global organization with more than 2,500 employees — including over 300 scientists — and a reputation as a preferred supplier to leading pharmaceutical companies worldwide. Throughout the interview, Diane highlights the values that have guided the company’s development: a commitment to excellence, a strong work ethic, and a focus on quality and long-term relationships. Although she did not have formal business training, she learned “on the job” and brought discipline, precision and structure to her role — particularly in the company’s early financial and administrative leadership. Now in her nineties and an active member of Hovione’s Board of Directors, Diane Villax remains engaged with the company’s evolution and governance, reflecting a continued commitment to its long-term development. Her story reflects entrepreneurial drive, resilience and long-term leadership — and offers insight into the values that have shaped Hovione’s trajectory for more than six decades. Read the full interview at Executiva.pt (in portuguese).    

Article

Hovione’s Diane Villax: “I was not brought up to be a business woman”

Feb 23, 2026